BiotequeROCO:4107 84 OCF Yield % is 8.23 as of Jul. 09, 2026, which is 20% above its 10-year median of 6.88. GuruFocus rates ROCO:4107 with a GF Score™ of 84/100 and a GF Value™ of NT$129.18 (Fairly Valued). Among 852 Medical Devices & Instruments companies, Bioteque ranks better than 80.87% on this metric.
OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
The historical rank and industry rank for Bioteque's OCF Yield % or its related term are showing as below:
ROCO:4107'
s OCF Yield % Range Over the Past 10 Years
Min: 3.46 Med: 6.88 Max: 10.54
Current: 8.23
During the past 13 years, the highest OCF Yield % of Bioteque was 10.54%. The lowest was 3.46%. And the median was 6.88%.
ROCO:4107's OCF Yield % is ranked better than 80.87% of 852
companies
in the Medical Devices & Instruments industry
Industry Median: 1.705
vs ROCO:4107: 8.23
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Bioteque OCF Yield % Related Terms
Bioteque OCF Yield % Historical Data
* Premium members only.
The historical data trend for Bioteque's OCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:4107 vs ISRG, BDX, MDLN: OCF Yield % Comparison
For the Medical Instruments & Supplies subindustry, Bioteque's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bioteque OCF Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Bioteque's OCF Yield % distribution charts can be found below:
* The bar in red indicates where Bioteque's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bioteque (ROCO:4107) has a OCF Yield % of 8.23 as of Jul. 09, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Bioteque and its competitors. This is 20% above median its historical median of 6.88. Over the past decade, Bioteque's OCF Yield % has ranged from 3.46 to 10.54. According to the industry distribution chart, Bioteque ranks #163 out of 852 companies in the Medical Devices & Instruments industry, placing it in the top 19.1%.
Is Bioteque's OCF Yield % too high?
Bioteque's current OCF Yield % of 8.23 is 20% above median its 10-year median of 6.88. Over the past 10 years, this metric has ranged from a low of 3.46 to a high of 10.54. The Medical Devices & Instruments industry median OCF Yield % is 1.71. Bioteque's value of 8.23 is 382.7% above this industry median. Based on the distribution chart, Bioteque ranks #163 out of 852 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Bioteque has a GF Score™ of 84/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Bioteque's OCF Yield % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Bioteque ranks #163 out of 852 companies for OCF Yield %. This places Bioteque in the top 19% of its industry — outperforming the majority of peers. The industry median OCF Yield % is 1.71. Bioteque's value of 8.23 is 382.7% above this benchmark. Historically, Bioteque's own OCF Yield % has ranged from 3.46 to 10.54 over the past decade. While the company's 10-year median is 6.88 vs. the industry median of 1.71, Bioteque has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Medical Devices & Instruments company?
The median OCF Yield % among Medical Devices & Instruments companies is 1.71, based on 852 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bioteque's current OCF Yield % of 8.23 is 382.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Bioteque and its competitors. For the Medical Devices & Instruments industry, the median OCF Yield % is 1.71 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bioteque's current OCF Yield % is 8.23, which is 20% above median its own 10-year median of 6.88. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bioteque stock overvalued right now?
Based on GuruFocus' analysis, Bioteque (ROCO:4107) is currently considered Fairly Valued. The stock's GF Value™ is NT$129.18, compared to a current price of NT$117.00 — trading 9.4% below its estimated fair value. The current OCF Yield % is 8.23, which is 20% above median its 10-year median of 6.88 and 382.7% above the Medical Devices & Instruments industry median of 1.71. Bioteque's overall GF Score™ is 84/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Bioteque (ROCO:4107), the current OCF Yield % is 8.23 as of Jul. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bioteque (ROCO:4107) Overvalued in 2026?
Based on GuruFocus' analysis, Bioteque stock appears to be undervalued.
The current stock price of NT$117.00 is trading 9.4% below its estimated GF Value™ of NT$129.18.
GuruFocus considers Bioteque to be Fairly Valued.
Key valuation signals for ROCO:4107:
OCF Yield %: 8.23 (20% above median its 10-year median of 6.88)
GF Value™: NT$129.18 vs. price of NT$117.00 (9.4% below fair value)
Industry Position: 382.7% above the Medical Devices & Instruments median (#163 of 852)
No single metric tells the full story. See the ROCO:4107 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bioteque Corp is engaged in manufacturing, trading, and selling medical equipment and instruments. The company operates in different segments such as Manufacturing medical disposables for hemodialysis use, and selling them to dealers and retailers; Manufacturing and selling catheters for healthcare and medical PVC IV bags to medical organizations; Manufacturing and selling medical key components and inner catheters to the medical organization; and Other segment. Geographically, the company generates a majority of its revenue from Asia and the rest from North America, South America, and other regions.
84GF Score
Get the complete analysis for ROCO:4107
OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:4107 has been successfully added to your 
